Abstract
Mr. Mario I. was 86-year-old man returning to nephrology clinic for follow-up of chronic kidney disease (CKD) stage IV/V in the setting of hypertension and presumed hypertensive nephrosclerosis. He had a history of uremia over the past 8 months with increased fatigue, somnolence, and anorexia; observed decreased attentiveness and increased need for assistance with activities of daily living (ADL) concerning to his wife; and it was increasing difficulty to control his edema and maintain euvolemia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moss AH. Renal Physicians Association, American Society of Nephrology Working Group. A new clinical practice guideline on initiation and withdrawal of dialysis that makes explicit the role of palliative medicine. J Palliat Med. 2000;3:253–60.
Sand P, Livingston G, Wright RG. Psychological assessment of candidates for a Hemodialysis program. Ann Intern Med. 1966;64:602–10.
Murray JS, Tu WH, Albers JB, Burnell JM, Scribner BH. A community center for the treatment of chronic uremia. Trans Am Soc Artif Intern Organs. 1962;8:315.
Lindholm DD, Burnell JM, Murray JS. Experience in the treatment of chronic uremia in an outpatient community dialysis center. Trans Am Soc Artif Intern Organs. 1963;9:3–10.
Social Security Amendment of 1972. Public Law 92-603, Section 2991. 1972 Oct 31.
Kurella Tamura M, Cohen LM. Should there be an expanded role for palliative care in end-stage renal disease? Curr Opin Nephrol Hypertens. 2010;19:556–60.
Blagg CR. The early history of dialysis for chronic renal failure in the United States: a view from Seattle. Am J Kidney Dis. 2007;49:482–96.
Knauf F, Aronson PS. ESRD as a window into America’s cost crisis in healthcare. J Am Soc Nephrol. 2009;20:2093–7.
Carson RC, Juszczak M, Davenport A, Burns A. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol. 2009;4:1611–9. Epub 2009 Sep 24.
Farrington K, Rao R, Gilg J, Ansell D, Feest T. Chapter 3. New adult patients starting renal replacement therapy in the UK in 2005. In: Ansell D, Feest T, Hodsman R, Rao R, Tomson C, Udayaraj U, Williams A, Warwick G, editors. UK Renal Registry: The Ninth Annual Report. Bristol, United Kingdom: The Renal Association; 2006. p. 15–41.
Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med. 2007;146:177–83.
Collins AJ, Foley R, Herzog C, et al. Excerpts from the United States Renal Data System 2007 annual report: ESRD incidence and prevalence. Am J Kidney Dis. 2008;51:S81–98.
US Renal Data System. USRDS 2010 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Kidney and Urologic Disease Information Clearinghouse, 3 Information Way, Bethesda, MD 20892-3560; 301.654.4415, nkudic@info.niddk.nih.gov.
Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2006 annual data report. Am J Kidney Dis. 2007;49(A6–7):S1–296.
Krishnan M, Lok CE, Jassal SV. Epidemiology and demographic aspects of treated end-stage renal disease in the elderly. Semin Dial. 2002;15:79–83.
Germain MJ, Cohen LM. Maintaining quality of life at the end of life in the end-stage renal disease population. Adv Chronic Kidney Dis. 2008;15:133–9. Review.
US Renal Data System. USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the united States, Bethesda, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 2005.
Davison SN. Chronic pain in end-stage renal disease. Adv Chronic Kidney Dis. 2005;12:326–34.
Davison SN, Jhangri GS, Johnson JA. Cross-sectional validity of a modified Edmonton Symptom Assessment System (ESAS) in dialysis patients: A simple method for the assessment of symptom burdens. Kidney Int. 2006;69:1621–5.
Register Canadian Organ Replacement. Dialysis and Renal Transplantation: Canadian Organ Replacement Register, 2001 Report. Canadian Institute for Health Information: Ottawa; 2002.
Renal Data US, System USRDS. Annual data report: Atlas of end-stage renal disease in the United States. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD: National Institutes of Health; 2007. 2007.
O’Hare AM, Choi AI, Berenthal D. Age effects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18:2758–65.
Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld S, McCulloch CE. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med. 2009;361:1539–47.
Cook WL, Jassal SV. Functional dependencies among the elderly on hemodialysis. Kidney Int. 2008;73:1289–95.
DeOreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalizations, and dialysis-attendance compliance. Am J Kidney Dis. 1997;30:204–12.
Davison SN. The prevalence and management of chronic pain in end-stage renal disease. J Palliat Med. 2007;10:1277–87.
Davison SN, Jhangri GS. The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Symptom Manage. 2005;30:465–73.
Davison SN, Jhangri GS, Johnson JA. Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transplant. 2006;21:3189–95.
Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life in hemodialysis patients. J Pain Symptom Manage. 2010;39:477–85.
Weisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic Hemodialysis patients. J Am Soc Nephrol. 2005;16:2487–94.
Chater S, Davison SN, Germain MJ, Cohn LM. Withdrawal from dialysis. A palliative care perspective. Clin Nephrol. 2006;66:364–72.
Davison SN. Pain in hemodialysis: prevalence, cause, severity, and management. Am J Kidney Dis. 2003;42:1239–47.
Fainsinger RL, Davison SN, Brenneis C. A supportive care model for dialysis patients. Palliat Med. 2003;17:81–2.
Fortina F, Agllata S, Ragazzoni E, et al. Chronic pain during dialysis. Pharmacologic therapy and its costs. Minerva Urol Nefrol. 1999;51:85–7.
Cohen LM, Germain M, Poppel DM, Woods A, Kjellstrand CM. Dialysis discontinuation and palliative care. Am J Kidney Dis. 2000;36:140–4.
United States Renal Data System: Causes of death. In: USRDS 1999 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1999, pp 89-100.
Holley JL. Palliative care in end-stage renal disease: focus on advance care planning, hospice referral, and bereavement. Semin Dial. 2005;18:154–6.
Rettig RA, Levinsky NG, editors. Kidney Failure and the Federal Government Committee for the Study of the Medicare ESRDS Program, Division of Health Care Services. Washington, DC: Institute of Medicine, National Academy Press; 1991.
Holley JL, Carmody SS, Moss AH, Sullivan AM, Cohen LM, Bloack SD, Arnold RM. The need for end-of-life care training in nephrology: national survey results of nephrology fellows. Am J Kidney Dis. 2003;42:813–20.
Perry E, Schwartz R, Smith-Wheelock L, et al. Why is it difficult for staff to discuss advance directives with chronic dialysis patients? J Am Soc Nephrol. 1996;7:2160–8.
Davison SN, Jhangri GS, Holley JL, Moss AH. Nephrologists’ reported preparedness for end-of-life decision-making. Clin J Am Soc Nephrol. 2006;1:1256–62. Epub 2006 Sep 13.
Hines SC, Glover JJ, Holley JL, et al. Dialysis patients’ preferences for family-based advance care planning. Ann Intern Med. 1999;130:825–8.
Holley JL, Hines SC, Glover JJ, et al. Failure of advance care planning to elicit patents’ preferences for withdrawal from dialysis. Am J Kidney Dis. 1999;33:688–93.
Singer PA. Advance care planning in dialysis. Am J Kidney Dis. 1999;33:980–91.
Neu S, Kjellstrand CM. Stopping long-term dialysis: An empirical study of withdrawal of life-supporting treatment. N Engl J Med. 1986;314:14–20.
Murray AM, Arko C, Chen SC, Gilbertson DT, Moss AH. Use of hospice in the United Stated dialysis population. Clin J Am Soc Nephrol. 2006;1:1248–55. Epub 2006 Sep 6.
Brown EA. Epidemiology of renal palliative care. J Palliative Med. 2007;10:1248–52.
Davison SN. End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:195–204. Epub 2010 Jan 14.
Kimmel PL, Emont SL, Newmann JM, Danko H, Moss AH. ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicity. Am J Kidney Dis. 2003;42:713–21.
Renal Physicians Association. Shared decision-making in the appropriate initiation of and withdrawal from dialysis. Clinical practice guideline. 2nd ed. Rockville, Maryland: October 2010. Pp. 1-10.
Holley JL. Palliative care in end-stage renal disease: illness trajectories, communication, and hospice use. Adv Chronic Kidney Dis. 2007;14:402–8.
Moss AH, Holley JL, Davison SN, et al. Core curriculum in nephrology: Palliative care. Am J Kidney Dis. 2004;43:172–85.
Chambers EJ, Germain M, Brown E. Supportive Care for the Renal Patient. Oxford University Press: Oxford, England; 2004.
Berzoff J, Swantkowski J, Cohen LM. Developing a renal supportive care team from the voices of patients, families, and palliative care staff. Palliat Support Care. 2008;6:133–9.
WHO definition of palliative care. http://www.who.int/cancer/palliative/definition/en/. [Accessed May 25, 2011.
Morrison RS, Meier DE. Clinical practice: palliative care. N Engl J Med. 2004;350:2582–90.
Kandoian EA. Due process in the allocation of scarce lifesaving medical resources. Yale Law School J. 1975;84:1734–49.
Holley JL, Nespor S, Rault R. The effects of providing chronic hemodialysis patients with material on advance directives. Am J Kidney Dis. 1993;22:413–8.
Davison SN, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ. 2006;333:886. Epub 2006 Sep 21. [doi:10:.1136/bmj:38965.626250.55].
Johnston SC, Pfeifer NP, McNutt R. for the End-of-Life Study Group. The discussion about advance directives. Patient and physician opinions regarding when and how it should be conducted. Arch Intern Med. 1995;155:1025–30.
Morrison RS, Morrison EW, Glickman DF. Physician reluctance to discuss advance directives. Arch Intern Med. 1994;154:2311–8.
Cohen LM, Germain M, Woods A, Gilman ED, McCue JD. Patient attitudes and psychological considerations in dialysis discontinuation. Psychosomatics. 1993;34:395–401.
Cohen LM, McCue JD, Germain M, Woods A. Denying the dying. Advance directives and dialysis discontinuation. Psychosomatics. 1997;38:27–34.
Moss AH, Hozayen O, King K, Holley JL, Schmidt RJ. Attitudes of patients toward cardiopulmonary resuscitation in the dialysis unit. Am J Kidney Dis. 2001;38:847–52.
Moss AH, Holley JL, Upton MB. Outcomes of cardiopulmonary resuscitation in dialysis patients. J Am Soc Nephrol. 1992;3:1238–43.
Carson V, Soeken K, Shanty J, Terry L. Hope and spiritual well-being: essentials for living with AIDS. Perspect Psychiatr Care. 1990;26:28–34.
Forbes M. Hope in older adults with illness. Appl Nurs Res. 1999;22:74–87.
Christakis NA. Death Foretold: Prophecy and Prognosis in Medical Care. Chicago: University of Chicago Press; 1999. p. 179.
Michel DM, Moss AH. Communicating prognosis in the dialysis consent process: a patient-centered guideline-supported approach. Adv Chronic Kidney Dis. 2005;12:196–201.
Weissman DE. Decision making at a time of crisis near the end of life. JAMA. 2004;292:1738–43.
Beddhu S, Bruns FJ, Saul M, et al. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med. 2000;108:609–13.
Miskulin DC, Martin AA, Brown R, et al. Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. Nephrol Dial Transplant. 2004;19:413–20.
Hudson M, Weisbord S, Arnold RM. Prognostication in patients receiving dialysis #191. J Palliat Med. 2007;10:1402–3.
Levinsky NG, Mesler DE. Measuring, managing, and improving the quality of end-stage renal disease. Am J Kidney Dis. 1994;24:235–46.
Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31:58–69.
Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT. Physical symptoms and quality of life in patients on chronic dialysis: Results of the Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Nephrol Dial Transplant. 1999;14:1163–70.
Curtin RB, Bultman DC, Thomas-Hawkins C, Walters BA, Schatell D. Hemodialysis patients’ symptom experiences: effects on physical and mental functioning. Nephrol Nurse J. 2002;29(562):567–74.
Flynn 3rd JJ, Mitchell MC, Caruso FS, McElligott MA. Midodrine treatment for patients with hemodialysis hypotension. Clin Nephrol. 1996;45:261–7.
Sklar AH, Riesenberg LA, Silber AK, Ahmed W, Ali A. Postdialysis fatigue. Am J Kidney Dis. 1996;28:732–6.
Robertson HT, Haley NR, Guthrie M, Cardenas D, Eschbach JW, Adamson JW. Recombinant erythropoietin improves exercise capacity in anemic Hemodialysis patients. Am J Kidney Dis. 1990;15:325–32.
Wuerth D, Finkelstein SH, Ciarcia J, Peterson R, Kliger AS, Finkelstein FO. Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis. 2001;37:1011–7.
Lew SQ, Albertini B, Bosch JP. The digestive tract. In: Daugirdas JT, Blake PG, Ing TS, editors. Handbook of Dialysis. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 601.
Boccanfuso JA, Hutton M, McAllister B. The effects of megestrol acetate on nutritional parameters in a dialysis population. J Ren Nutr. 2000;10(1):36–43.
Lien YH, Ruffenach SJ. Low dose megestrol increases serum albumin in malnourished dialysis patients. Int J Artif Organs. 1996;19:147–50.
Kimmel PL, Miller G, Mendelson WB. Sleep apnea syndrome in chronic renal disease. Am J Med. 1989;86:308–14.
Mendelson WB, Wadhwa NK, Greenberg HE, Gujavarty K, Bergofsky E. Effects of hemodialysis on sleep apnea syndrome in end-stage renal disease. Clin Nephrol. 1990;33:247–51.
Gigli GL, Adorati M, Dolso P, Piani A, Valente M, Brotini S, Budai R. Restless legs syndrome in end-stage renal disease. Sleep Med. 2004;5:309–15.
Smith MD, Hong BA. Diagnosis of depression in patients with end-stage renal disease. Comparative analysis. Am J Med. 1985;79:160–6.
Davison S. Chronic kidney disease: psychosocial impact of chronic pain. Geriatrics. 2007;62:17–23.
Murtagh FEM, Addington-Hall JM, Edmonds PM, Donohoe P, Carey I, Jenkins K, Higginson IJ. Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med. 2007;10:1266–76.
Cohen LM, Moss AH, Weisbord SD, Germain MJ. Renal palliative care. J Palliative Med. 2006;9:977–92.
Douglas C, Murtagh FEM, Chambers EJ, Howse M, Ellershaw J. Symptom management for the adult patient dying with advanced kidney disease: a review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group. Palliat Med. 2009;23:103–10.
Barakzoy AS, Moss AH. Efficacy of the World Health Organization analgesic ladder to treat pain in end-stage renal disease. J Am Soc Nephrol. 2006;17:3198–203.
Kurella M, Bennett WM, Chertow GM. Analgesia in patients with ESRD: a review of available evidence. Am J Kidney Dis. 2003;42:217–28.
Pham P-CT, Toscano E, Pham P-MT, Pham P-AT, Pham SV, Pham P-TT. Pain management in patients with chronic kidney disease. NDT Plus. 2009;2:111–8.
Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004;28:497–504.
Launay-Vacher V, Karie S, Fau J-B, Izzedine H, Deray G. Treatment of pain in patients with renal insufficiency: The World Health Organization three-step ladder adapted. J Pain. 2005;6:137–48.
Davison SN, Davison JS. Is there a legitimate role for the therapeutic role of cannaboids for symptom management in chronic kidney disease? J Pain Symptom Manage. 2011;41:768–78.
Deaths, Percent of Total Deaths, and Death Rates for the 15 Leading Causes of Death in Selected Age Groups, by Race and Sex: United States, 2000. Available: http://www. cdc.gov/nchs/data/dvs/LCWK3_2000.pdf.
Moss AH. Improving end-of-life care for dialysis. Editorial. Am J Kidney Dis. 2005;45:209–12.
Cohen LM, Ruthazer R, Moss AH, Germain MJ. Predicting six-month mortality for patients who are on maintenance Hemodialysis. Clin J Am Soc Nephrol. 2010;5:72–9. Epub 2009 Dec 3.
Renal Physicians Association, American Society of Nephrology: Clinical Practice Guideline on Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis, Washington, DC, Renal Physicians Association, 2000.
Moss AH. Renal Physicians Association, American Society of Nephrology Working Group. Shared decision making in dialysis: a new clinical practice guideline to assist with dialysis-related ethics consultations. J Clin Ethics. 2001;12:406–14.
Renal Physicians Association, American Society of Nephrology: Position Paper on Quality Care at the End of Life, Rockville, Renal Physicians Association, 2002
Davison SN. Integrating palliative care for patients with advanced chronic kidney disease: recent advance, remaining challenges. J Palliat Care. 2011;27:53–61.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wasserman, J.C. (2013). Palliative Care in Renal Disease. In: Lerma, E., Rosner, M. (eds) Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4454-1_33
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4454-1_33
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4453-4
Online ISBN: 978-1-4614-4454-1
eBook Packages: MedicineMedicine (R0)